Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,134 | 25,771 | 20,681 | 17,916 | 19,704 |
| Receivables | 20,883 | 17,655 | 18,976 | 17,579 | 17,589 |
| Inventories | 20,531 | 15,777 | 17,762 | 18,160 | 15,832 |
| Income taxes - deferred | 1,515 | 1,547 | 1,553 | 3,908 | 5,441 |
| TOTAL | $57,063 | $60,750 | $58,972 | $57,563 | $58,566 |
| Non-Current Assets | |||||
| PPE Net | 5,190 | 4,375 | 4,551 | 3,086 | 3,146 |
| Intangibles | 62,227 | 56,903 | 58,701 | 57,845 | 56,600 |
| Other Non-Current Assets | 11,436 | 13,432 | 11,260 | 8,140 | 6,485 |
| TOTAL | $78,853 | $74,710 | $74,512 | $69,071 | $66,231 |
| Total Assets | $135,916 | $135,460 | $133,484 | $126,634 | $124,797 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,000 | 5,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 6,294 | 4,682 | 4,680 | 4,959 | 4,925 |
| Accrued Expenses | 5,006 | 5,177 | 4,011 | 3,574 | 5,271 |
| Other current liabilities | 1,023 | 586 | 728 | 543 | 649 |
| TOTAL | $18,099 | $16,085 | $9,901 | $9,559 | $11,296 |
| Non-Current Liabilities | |||||
| Long Term Debt | 16,450 | 19,750 | 12,950 | 16,300 | 18,009 |
| Deferred Revenues | 655 | 640 | 482 | 483 | 451 |
| Other Non-Current Liabilities | 4,574 | 4,980 | 6,143 | 4,907 | 4,290 |
| TOTAL | $22,349 | $24,890 | $19,370 | $21,576 | $23,253 |
| Total Liabilities | $40,448 | $40,975 | $29,271 | $31,135 | $34,549 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,165 | 31,639 | 30,009 | 28,753 | 28,389 |
| Common Shares | 397 | 390 | 370 | 362 | 361 |
| Retained earnings | -92,684 | -95,039 | -77,260 | -79,630 | -83,442 |
| Other shareholders' equity | -7,901 | -2,312 | -4,531 | -5,390 | -3,564 |
| TOTAL | $95,468 | $94,485 | $104,213 | $95,499 | $90,248 |
| Total Liabilities And Equity | $135,916 | $135,460 | $133,484 | $126,634 | $124,797 |